GW28-e0461 Durations of Anticoagulation and Major Bleeding Risk of Vitamin K Antagonists for Venous Thromboembolism: A Meta-Analysis

Wei Wang,Chunyan Wu,Han Yu,Yang Yang,Jue Li

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2017）

引用 0|浏览5

暂无评分

摘要

VTE is regarded as the third general cause of cardiovascular disease beyond myocardial infarction and stroke. Vitamin K antagonists (VKA) are the mainstay of long-term anticoagulant therapy. Warfarin remains the primary approach which efficacy is well established. Although the emerging alternatives-

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要